Tafluprost

Synonyms: AFP-168,MK2452

Tafluprost (AFP-168,MK2452) is a novel prostaglandin analog with a high affinity for the fluoroprostaglandin (FP) receptor PGF2α. A prostanoid selective FP receptor agonist.

Tafluprost Chemical Structure

Tafluprost Chemical Structure

CAS: 209860-87-7

Purity & Quality Control

Batch: S485101 Purity: 99.02%
99.02

Choose Selective Prostaglandin Receptor Inhibitors

Biological Activity

Description Tafluprost (AFP-168,MK2452) is a novel prostaglandin analog with a high affinity for the fluoroprostaglandin (FP) receptor PGF2α. A prostanoid selective FP receptor agonist.
Targets
PGF2α [1]
NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT04828057 Completed Ocular Surface Disease|Primary Open Angle Glaucoma Santen Pharmaceutical (Taiwan) Co. LTD September 1 2021 --
NCT03612817 Completed Glaucoma Open-Angle Aristotle University Of Thessaloniki|Santen Oy January 2017 Phase 4
NCT02102750 Completed Glaucoma|Ocular Hypertension Santen Oy June 2014 Phase 1
NCT03104621 Completed Primary Open-angle Glaucoma Gangnam Severance Hospital March 2013 Phase 4

Chemical lnformation & Solubility

Molecular Weight 452.53 Formula

C25H34F2O5

CAS No. 209860-87-7 SDF --
Density 1.186 g/mL
Smiles CC(C)OC(=O)CCCC=CCC1C(CC(C1C=CC(COC2=CC=CC=C2)(F)F)O)O
Storage (From the date of receipt) 2 years -80°C liquid

In vitro
Batch:


Molecular Weight Calculator

In vivo
Batch:

Add solvents to the product individually and in order.


In vivo Formulation Calculator

Preparing Stock Solutions

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Tafluprost | Tafluprost ic50 | Tafluprost price | Tafluprost cost | Tafluprost solubility dmso | Tafluprost purchase | Tafluprost manufacturer | Tafluprost research buy | Tafluprost order | Tafluprost mouse | Tafluprost chemical structure | Tafluprost mw | Tafluprost molecular weight | Tafluprost datasheet | Tafluprost supplier | Tafluprost in vitro | Tafluprost cell line | Tafluprost concentration | Tafluprost nmr